pretickt

CRSP peers and competitors

CRISPR Therapeutics AG · end-of-day data as of Nov 13, 2026

CRISPR Therapeutics
CRSP · $4.1B
$42.24-0.9%
Nov 13, 2026 · close
$50$60SepOctNov9:3016:003 months -20.3%Nov 13 · close
▲ 4
  • PT$72.45 +71.5%
  • ConsensusBuy · 23
  • Bollingerbelow lower
  • Sector▲ +15.9%
Neutral
  • Earnings in90d
  • RSI32
  • Support-7.6%
  • Resistance+0.3%
  • Off 52w high-33.4%
  • Volume1.2x
  • News0.00
  • Trendsideways
  • 52w range$42–$63
  • ATR+6.3%
  • Off ATH-80.8%
▼ 4
  • FCF yield-9.3%
  • Insiders-$4.88M
  • MAs0 of 4
  • MACD-0.81

Updates with the 15-min delayed price. Not a forecast or investment advice.

The peers of CRISPR Therapeutics CRSP by industry and size include Vertex VRTX, Regeneron REGN and Moderna MRNA. Among these 12 companies CRISPR Therapeutics CRSP ranks 11th by market cap ($4.1B).

Peers by industry and size

20D
1VRTXVertex$538.60-0.7%-5.3%+6.6%34.7$137B
2REGNRegeneron$955.47+0.4%-3.7%-6.4%21.1$98.82B
3MRNAModerna$223.37-3.4%-20.5%-45.2%—$90.38B
4INCYIncyte$120.97-0.6%-8.8%+9.8%64.3$24.66B
5ALNYAlnylam$165.04+5.4%-65.6%+113.7%8.3$22.11B
6TECHBio-Techne$72.80+0.1%-0.1%-7.7%66.2$11.44B
7PODDInsulet$152.48+2.1%-57.0%+19.5%24.8$10.58B
8UHSUniversal Health Services$194.07+0.1%-21.2%-0.4%8.1$9.78B
9HSICHenry Schein$86.22+0.1%-6.5%+7.1%23.6$9.53B
10TWSTTwist Bioscience$111.60-2.3%-49.2%+30.6%—$7.35B
11CRSPCRISPR Therapeutics$42.24-0.9%-33.4%+71.5%—$4.1B
12VCYTVeracyte$24.33-1.2%-60.1%+122.5%15.8$1.96B

Data as of Nov 13, 2026 close.